Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver of idiopathic pulmonary fibrosis (IPF), a chronic ...

The Illinois EPA declared an Air Pollution Action Day in the Chicago metro area. See today's air quality index forecast for Illinois.

Balloon pulmonary angioplasty led to clinical improvements and relatively low complication rates for CTEPH patients in a ...

The correspondence of Joan B Soriano and Alberto Ruano-Ravina deserves timely praise, highlighting the threat that predatory ...

The CAAT governance board recommends transitioning from the COPD Assessment Test to the CAAT and using it for patients with ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The pulmonary arterial hypertension market is expected to reach USD 2,080.7 million by 2025 and is expected to steadily grow at a CAGR of 2.3% to reach USD 2,612.0 million by 2035.

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins ...

Negative pressure pulmonary edema (NPPE) is a form of non-cardiogenic pulmonary edema triggered by a swift increase in negative intrapleural pressure due to upper airway obstruction and represents a ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.